India Medical Devices Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

India Medical Devices Market Trends and Insights

Rising Prevalence of Chronic & Lifestyle Diseases

Non-communicable disorders now dominate India’s disease burden, creating a continuous pull for sophisticated equipment to detect, monitor, and treat long-term conditions. Diabetes cases are projected to jump from 77 million in 2025 to 134.2 million by 2045, magnifying demand for glucose monitors, insulin pumps, and remote telemetry solutions. Incidence of cardiovascular conditions is likewise increasing, encouraging wider deployment of high-throughput diagnostic imaging systems and interventional cardiology products. Urban lifestyles—marked by sedentary habits and dietary shifts—are accelerating obesity, hypertension, and related morbidities, all of which call for continuous vital-sign tracking outside hospital walls. At the same time, an aging demographic is lengthening care cycles, making durable home-care devices commercially attractive. These trends collectively extend the growth runway for the India medical devices market well past typical health-spending cycles.

Government Production-Linked Incentive Scheme

The PLI scheme earmarks INR 3,420 crore for medical devices from 2020-21 to 2027-28, supporting 32 approved projects that collectively bring INR 1.46 lakh crore investment into local manufacturing of 39 device categories. Thirteen new greenfield plants^{[1]Press Information Bureau, “Dr Mansukh Mandaviya Inaugurates 27 Greenfield Bulk Drug Park projects and 13 Greenfield Manufacturing Plants for Medical Devices under the PLI Scheme,” pib.gov.in} already produce complex products such as MRI and CT systems, once fully imported, reducing supply‐chain risk from currency swings and geopolitical tensions. Technology transfer agreements^{[2]Press Information Bureau, “PLI scheme incentivizes domestic manufacturing, increases production, creates new jobs and boosts exports,” pib.gov.in} under the program are localizing high-value components, shrinking lead times for Indian buyers and widening the domestic talent base in advanced manufacturing. As cost savings flow through purchasing budgets of hospital groups, procurement policies increasingly favor “Made in India” offerings, accelerating penetration for homegrown brands across the India medical devices market.

Expansion of Private Hospital Networks

Hospital capacity more than doubled between 2020 and 2023, moving beyond metros into tier-2 and tier-3 cities. New entrants outfit facilities with full imaging suites, surgical platforms, and point-of-care diagnostics to match metro standards, creating consistent demand pipelines for suppliers. Chain operators centralize purchasing, improving forecast visibility for vendors and encouraging bundled sales of devices plus service contracts. To connect dispersed locations with specialist expertise, networks are adopting tele-ICU and remote diagnostics, opening new revenue layers for connected devices. Such expansion sustains equipment refresh cycles and builds overall ecosystem readiness for higher-end technologies in the India medical devices market.

Domestic Med-Tech Start-Ups Leveraging Frugal Innovation

Start-ups such as InnAccel and Saans lower acquisition costs by up to 50% versus imports while maintaining clinical efficacy, targeting volume-driven segments like maternal-and-child health and emergency care. Venture capital funding supports rapid prototyping and global patent filings, elevating Indian intellectual property footprints. Frugal design principles emphasize low-maintenance and battery-backed operation—features critical for semi-urban and rural facilities dealing with intermittent power. As tendering authorities weigh lifecycle costs, these locally engineered solutions gain preference, broadening competitive diversity in the India medical devices market.

Stringent Regulatory Approval Timelines

Central Drugs Standard Control Organisation (CDSCO) reviews for Class C and Class D devices can extend to 12 months, introducing launch uncertainty that deters smaller innovators. Lengthy queries and additional dossier requests inflate compliance costs, prompting certain manufacturers to shift final assembly to Vietnam or Malaysia, where approvals are faster. While digitization initiatives aim to streamline filings, the current lag constrains speed-to-market and slows capital rotation, clipping near-term growth of the India medical devices market.

Price-Cap Regulations on Stents & Implants

The National Pharmaceutical Pricing Authority caps bare-metal stents at INR 10,692.69 and drug-eluting stents at INR 38,933.14, with annual revisions tied narrowly to wholesale price indices. Such ceilings compress margins on R&D-intensive devices, discouraging rapid roll-outs of next-generation therapies by multinational firms. Although domestic producers may gain share, overall innovation velocity risks slowing, tempering value growth inside the India medical devices market.

Segment Analysis

By Device Type: Therapeutic Devices Drive Market Leadership

Therapeutic devices generated 35.79% of 2024 revenue, emphasizing India’s treatment-oriented care model, where hospitals direct capital budgets toward devices that deliver immediate interventions. Revenue concentration aligns with reimbursement practices that favor procedure-linked billing over preventive screening. Monitoring devices, in contrast, post an 8.46% CAGR as remote patient management programs expand in response to chronic disease loads. Diagnostic imaging maintains a stable uptick, reflecting private-hospital competition to offer multi-modality radiology suites beyond metros. 

The leadership of therapeutic devices in the India medical devices market hinges on a pipeline of high-end imports gradually giving way to local production under PLI. Indigenous MRI prototypes developed at AIIMS illustrate how academic-industry collaboration can repatriate spending from imports to domestic suppliers. Meanwhile, niche areas like dental and endoscopy continue steady but smaller-scale adoption, aided by rising insurance coverage and medical tourism inflows seeking specialty services.

Note: Segment shares of all individual segments available upon report purchase

By Technology Platform: Conventional Dominance Amid Digital Transformation

Cost-effective electro-mechanical and disposable devices account for 62.54% of 2024 sales, highlighting hospitals’ prioritization of reliability and low maintenance. Yet augmented/virtual-reality training simulators and intra-operative overlays are scaling quickly at 10.29% CAGR as surgical departments aim for higher precision. Wearables and remote sensors resonate with chronic-care pathways that shift monitoring to patients’ homes, pushing connected-device penetration deeper into the India medical devices market. 

Robotic surgery systems exemplify premium-tech adoption that accelerates when public hospitals like the Regional Cancer Centre install flagship units. Parallel growth in tele-health platforms, supported by the Ayushman Bharat Digital Mission, expands addressable endpoints for mHealth peripherals. Although 3D-printed implants and nanotech remain embryonic, research pilots in orthopedic trauma indicate long-term disruptive potential.

By Therapeutic Application: Cardiology Leadership Reflects Disease Burden

Cardiovascular devices led revenues with a 24.28% share in 2024, mirroring the country’s high mortality from heart disease. Demand spans diagnostic ECGs, interventional cath-lab gear, and long-term implantable devices. Neurology shows the fastest trajectory at 8.57% CAGR, fueled by growing awareness and specialty-clinic expansion into tier-2 cities. Orthopedic implants retain healthy growth as sedentary lifestyles and aging accelerate joint degeneration. 

Ophthalmology benefits from diabetes-linked retinopathy screening programs, boosting fundus cameras and intraocular lens sales. Oncology and minimally invasive general surgery likewise gain traction as hospitals pursue technology-driven differentiation. Adoption of robotic platforms such as the system used for India’s first robotic-assisted prostatic stromal tumor excision signals a tilt toward precision surgery within the India medical devices market.

By End-User: Hospital Dominance Amid Care-Setting Diversification

Hospitals absorbed 89.06% of device expenditure in 2024, a legacy of centralized, physician-led care pathways. Capital-intensive imaging and surgical equipment remain rooted in institutional environments requiring specialized utilities and biomedical engineers. Nonetheless, clinic networks expand at 9.08% CAGR, capturing outpatient diagnostics and day procedures in urbanizing districts. 

Home-care demand grows alongside tele-consult adoption, widening channels for portable ventilators, infusion pumps, and wearable glucose monitors. As payers reimburse remote follow-ups, manufacturers craft service bundles that pair hardware with data dashboards, embedding subscription revenue into the India medical devices market. Diagnostic labs, ambulatory surgical centers, and research institutes round out demand diversity, each pulling specialized device subsets.

Geography Analysis

South India leads the India medical devices market with a 35.13% share in 2024, leveraging decades-old engineering clusters and export-oriented logistics through Chennai and Bengaluru ports. The state-backed Tamil Nadu Medical Devices Park offers common testing facilities, easing entry barriers for small producers. Academic centers like IIT Madras supply research talent, while hospital brands such as Apollo generate early-adopter demand for advanced technologies. 

North India, anchored by Delhi’s policy ecosystem, is scaling device deployment across varied income bands. The Greater Noida manufacturing corridor targets oncology and imaging equipment^{[3]Center for Strategic and International Studies, “States Weekly: June 25 2025,” csis.org}, aligning state efforts with federal incentives to localize production. Telemedicine bridges gaps between urban tertiary centers and rural districts^{[4]Mondal, Himel, “Current distribution of medical colleges in India and its potential predictors: A public domain data audit,” Journal of Family Medicine and Primary Care, journals.lww.com}, effectively broadening the catchment radius for device-enabled healthcare. 

East & North-East India records a 9.13% CAGR, the fastest nationwide, as states upgrade tertiary hospitals and introduce robotic surgery in public facilities. Enhanced air connectivity and dedicated health corridors are beginning to lift patient inflows, encouraging vendors to establish regional warehouses for quicker turnaround. West & Central India leverages Gujarat’s broader USD 1 trillion manufacturing ambition to attract component suppliers, while Maharashtra’s FDI pipeline supports multinational plants and a thriving medical tourism draw that feeds high-end device demand. 

Collectively, these geographic dynamics ensure that the India medical devices market grows not only in absolute terms but also in depth, as previously underserved regions acquire the infrastructure needed to absorb sophisticated technologies.